Skip to content
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
TNC FlipBook Classic items
2024-06-19_PR_Atlas_financing_EN
By
admin
June 20, 2024
2024-06-19_CP_Financement_Atlas_FR
By
admin
June 19, 2024
2024-06-19_PR_Atlas_financing_EN
By
admin
June 19, 2024
2024_06_12_CP_Transfert_industriel_production_BIO101_FR
By
admin
June 14, 2024
2024_06_12_PR_Industrial_transfer_production_BIO101_EN
By
admin
June 14, 2024
2024-06-10_CP_IND_OBA_FDA_FR
By
admin
June 10, 2024
2024-10-06_PR_OBA_IND_FDA_EN
By
admin
June 10, 2024
2024-06-07_PR_CGM_June_24_2024_EN
By
admin
June 10, 2024
2024-06-07_CP_AG_24_Juin_2024_FR
By
admin
June 10, 2024
2024_05_14_PR_OBA_phase_2_design_EN
By
admin
May 14, 2024
←
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
…
27
28
29
30
31
…
32
33
34
→
Go to Top
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
